{"retracted":true,"timestamp":1435708800000,"update":{"timestamp":null,"doi":null,"pmid":26839122,"type":"retraction"},"doi":"10.1007/s11095-015-1625-2","journal":"Pharmaceutical research","publisher":null,"title":"RGD Peptide-Pegylated PLLA Nanoparticles Containing Epirubicin Hydrochloride Exhibit Receptor-Dependent Tumor Trafficking In Vitro and In Vivo."}
